Skip to main content
Industry News
Twist, Neogene partner on personalized cancer therapies

Twist Bioscience will collaborate with Neogene Therapeutics to develop personalized oncologic chimeric antigen receptor T-cell therapies and T-cell-receptor therapies. As part of the deal, Twist will design a specialized TCR library that will be used to discover engineered TCRs for two specific cancer T-cell targets.

Full Story: